Found 8 matching trials
Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration
PHASE1The present study will be conducted in order to compare the bioavailability...
Location
SocraTec R&D GmbH Clinical Pharmacology Unit
Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease
PHASE1The objective of this study is to evaluate the pharmacokinetics of deferipr...
Location
CHUM-Hôpital Notre-Dame
Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™
PHASE3This study is designed to evaluate in a controlled manner the effect of Pre...
Location
Multiple Locations
Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects
PHASE4Randomized, single-dose, double-blind, placebo and active controlled, four-...
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers
PHASE4Multi-center, non-randomized, open-label, single-dose, parallel group study...
Location
University of Miami
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
PHASE4This research is being done so that we can look at the safety and efficacy ...
Location
Children's Hospital Oakland
Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias
PHASE4This is a long-term follow-up to an earlier study, LA38-0411. Its purpose i...
Location
UCSF Benioff Children's Hospital Oakland
Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis
N/ASuperficial siderosis is a progressive neurological disease caused by iron ...
Location
Johns Hopkins University